Table of Contents PART 01: Executive summary PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Immunoassays • Immunodiagnostic instruments PART 07: Market segmentation by application • Global oncology and endocrinology market • Global hepatitis and retrovirus testing market • Global infectious disease testing market • Global GI stool testing market • Others market PART 08: Market segmentation by end-users • Hospitals and diagnostic laboratories • POLs PART 09: Geographical segmentation • Immunodiagnostics market in Americas • Immunodiagnostics market in EMEA • Immunodiagnostics market in APAC PART 10: Market drivers • Technological advances • Increasing adoption of POCT • Product development PART 11: Impact of drivers PART 12: Market challenges • Limited capability and high complexity of the procedure • Lack of skilled technicians • Uneven reimbursement scenario • Growing concern over standardization and quality of immunoassay kits PART 13: Impact of drivers and challenges PART 14: Market trends • Automation and system integration • Increased demand for biomarker-based tests • Growing use of multiplex bead-based immunoassays PART 15: Vendor landscape • Competitive scenario • Key news PART 16: Key vendor analysis • Abbott Laboratories • Danaher • Roche Diagnostics • Siemens Healthineers • Other prominent vendors PART 17: Appendix • List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Global immunodiagnostics market: Segment analysis 2016 Exhibit 02: Product offerings Exhibit 03: Global immunodiagnostics market overview Exhibit 04: Global immunodiagnostics market analysis 2016 and 2021 Exhibit 05: Global immunodiagnostics market 2016-2021 ($ billions) Exhibit 06: Five forces analysis Exhibit 07: Segmentation of global immunodiagnostics market by products Exhibit 08: Segmentation of global immunodiagnostics market by products 2016 Exhibit 09: Global immunoassays market 2016-2021 ($ billions) Exhibit 10: Global immunoassays market analysis 2016 and 2021 Exhibit 11: Global immunodiagnostic instruments market 2016-2021 ($ billions) Exhibit 12: Global immunodiagnostic instruments market analysis 2016 and 2021 Exhibit 13: Global immunodiagnostics market by application Exhibit 14: Global immunodiagnostics market by application 2016 Exhibit 15: Global oncology and endocrinology market 2016-2021 ($ billions) Exhibit 16: Common cancers worldwide 2015 Exhibit 17: Common causes of cancer deaths 2015 Exhibit 18: Estimated worldwide diabetes population 2015 and 2040 Exhibit 19: Global hepatitis and retrovirus testing market 2016-2021 ($ billions) Exhibit 20: Global HIV population by country 2015 Exhibit 21: Global infectious disease testing market 2016-2021 ($ billions) Exhibit 22: Global GI stool testing market 2016-2021 ($ billions) Exhibit 23: Global others market 2016-2021 ($ billions) Exhibit 24: Global autoimmune disease diagnostics market by systemic diseases 2016 Exhibit 25: Global immunodiagnostics market by end-users Exhibit 26: Global immunodiagnostics market by end-users 2016 Exhibit 27: Various types of reference measurement services Exhibit 28: Global clinical reference laboratory services market Exhibit 29: Global clinical reference laboratory services market share 2015 & 2020 (%) Exhibit 30: Geographic segmentation of global immunodiagnostics market (% revenue) Exhibit 31: Immunodiagnostics market in Americas 2016-2021 ($ billions) Exhibit 32: Immunodiagnostics market in EMEA 2016-2021 ($ billions) Exhibit 33: Immunodiagnostics market in APAC 2016-2021 ($ billions) Exhibit 34: Product offerings of automated diagnostics Exhibit 35: Impact of drivers Exhibit 36: Impact of drivers and challenges Exhibit 37: Global immunodiagnostics market share 2016 Exhibit 38: Competitive structure analysis of global immunodiagnostics market 2015 Exhibit 39: Competitive scenario for global immunodiagnostics market Exhibit 40: Abbott Laboratories profile Exhibit 41: Abbott Laboratories strength assessment Exhibit 42: Abbott Laboratories strategy assessment Exhibit 43: Abbott Laboratories opportunity assessment Exhibit 44: Danaher strength assessment Exhibit 45: Danaher strategy assessment Exhibit 46: Danaher Corporation opportunity assessment Exhibit 47: Key highlights of Roche Diagnostics Exhibit 48: Roche Diagnostics strength assessment Exhibit 49: Roche Diagnostics strategy assessment Exhibit 50: Roche Diagnostics opportunity assessment Exhibit 51: Key highlights of Siemens Healthineers Exhibit 52: Siemens Healthineers strength assessment Exhibit 53: Siemens Healthineers strategy assessment Exhibit 54: Siemens Healthineers opportunity assessment

Abbott Laboratories, Danaher, Roche Diagnostics, Siemens Healthineers, Adaptive Biotechnologies, AESKU Diagnostics, Alere, Amarantus Bioscience Holdings, Autoimmune Technologies, Avant Diagnostics, Axis-Shield Diagnostics, bioMérieux, DiaSorin, ERBA Diagnostics, Euro Diagnostica, Exagen Diagnostics, Gold Standard Diagnostics, HOB Diagnostics, HUMAN Diagnostics, IMMCO, Inova Diagnostics, Myriad Genetics, Nexus Dx, Omega Diagnostics, OraSure Technologies, ORGENTEC Diagnostika, Protagen, QIAGEN, Quest Diagnostics, Samsung Electronics, Seramun Diagnostica, SQI Diagnostics, Tecan, Thermo Fisher Scientific, Trillium Diagnostics.